Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Loading…
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin‐experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan‐Asian, treat‐to‐target Phase 3 Trial: 在既往使用胰岛素治疗血糖未得到控制的日本2型糖尿病受试者中比较德谷胰岛素/门冬胰岛素与每日2次双相门冬胰岛素30:泛亚达标治疗3期试验亚组分析
Taneda, Shinji, Hyllested‐Winge, Jacob, Gall, Mari‐Anne, Kaneko, Shizuka, Hirao, Koichi
Published in Journal of diabetes (01.03.2017)
Published in Journal of diabetes (01.03.2017)
Get full text
Journal Article
Loading…
Lower rates of hypoglycemia during maintenance treatment with insulin degludec/insulin aspart versus biphasic insulin aspart 30: a combined analysis of two Phase 3a studies in type 2 diabetes
Christiansen, Jens Sandahl, Niskanen, Leo, Rasmussen, Søren, Johansen, Thue, Fulcher, Greg
Published in Journal of diabetes (01.09.2016)
Published in Journal of diabetes (01.09.2016)
Get full text
Journal Article
Loading…
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin‐experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan‐Asian, treat‐to‐target Phase 3 Trial
Taneda, Shinji, Hyllested‐Winge, Jacob, Gall, Mari‐Anne, Kaneko, Shizuka, Hirao, Koichi
Published in Journal of diabetes (01.03.2017)
Published in Journal of diabetes (01.03.2017)
Get full text
Journal Article